Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer
Clinical trial NCT00723125 · COMPLETED
Trial details
- NCT number
- NCT00723125
- Sponsor
- William Sikov MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2014-05-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.